Skip to main content

Table 1 Patient cohort characteristics

From: Influence of cigarette smoking on the human duodenal mucosa-associated microbiota

 

Current

Previous

Never

p valuea

Overall cohort

Functional dyspepsia/iron deficiency

 Female, n (%)

7 (50)

20 (60.6)

15 (42.9)

0.34b

42 (51.2)

 Age, median (range)

49.1 (28.3–65.5)

62 (20.1–78.6)

45.8 (17.2–77.5)

0.02c,d

54.7 (17.2–78.6)

 BMI, mean (SD)

28.6 (7.6)

27.1 (5.5)

27.1 (6.2)

0.8e

27.3 (6.2)

 Patient—Functional/iron deficiency, n (%)

14 (100)/0 (0)

27 (81.8)/6 (18.2)

26 (74.3)/9 (25.7)

0.11b

67 (81.7)/15 (18.3)

 Current PPI use, n (%)

8 (57.1)

19 (57.6)

19 (54.3)

0.84b

46 (56.1)

 Country of birth—Australia/others, n (%)

9 (64.3)/5 (35.7)

19 (57.6)/14 (42.4)

20 (57.1)/15 (42.9)

0.89b

48 (58.5)/34 (41.5)

Crohn’s disease

 Female, n (%)

5 (71.4)

4 (57.1)

5 (83)

0.59b

14 (70)

 Age, median (range)

36.4 (22.2–57.9)

50.2 (37.5–59.0)

47.5 (22.2–61.9)

0.34c

45.6 (22.2–61.9)

 BMI, mean (SD)

30.2 (7.3)

32.2 (6.9)

26.7 (5.4)

0.46e

30.0 (7.0)

 Current PPI use, n (%)

0 (0)

0 (0)

3 (50)

0.07f

3 (15)

 Country of birth—Australia/others, n (%)

7 (100)/0 (0)

6 (85.7)/1 (14.3)

3 (50)/3 (50)

0.07b

16 (80)/4 (20)

  1. a Between smoking status. b p values based on chi-squared test. c p values based on Kruskal-Wallis test. d On Dunn’s multiple comparison test, only Previous vs Never was significantly different (p = 0.03). e p values based on ANOVA. f p values based on Fisher’s exact test. BMI—body mass index. PPI—proton pump inhibitor